Achieving high maturation and cannulation rates of radial-cephalic arteriovenous fistulas with VasQ™ device

Background Hemodialysis is the predominant treatment modality for chronic kidney disease, with arteriovenous fistula (AVF) being considered to be the preferred type of long-term vascular access. Implantation of the external anastomotic VasQ (TM) support device during AVF creation has been suggested to improve the functional outcomes of AVFs. In the current study, we report the clinical outcomes when using the device with radial-cephalic AVF (RCAVF) creation in a large cohort over 3 years. Methods One hundred fifty RCAVFs were created between June 2018 and August 2021 with implantation of VasQ (TM). Time to maturation, cannulation characteristics, and assisted (AP) and secondary patency (SP) rates were analyzed. Results In this predominantly male (68%), median 64 years old cohort, 150 VasQ (TM) devices were implanted. Physiological maturation was achieved in 142/150 (95%) and was unassisted in 133/150 (89%). Of those, 129 matured within 1 month and four additional AVFs within 165 days. Eight AVFs achieved maturation following percutaneous transluminal angioplasty, and one required surgical patch angioplasty. The median time from creation to first successful cannulation in dialysis patients was 41 days. AP at 6, 12, 18, 24, and 30 months was 89%, 81%, 78%, 73%, and 73%, and SP was 94%, 87%, 86%, 84%, and 84%, respectively. Conclusions Consistent use of the VasQ (TM) device in RCAVF creation demonstrates excellent AVF maturation and patency rates with very low frequency of assisted maturation and interventions for maintenance. The VasQ (TM) device appears a suitable aid in increasing the creation of functional RCAVFs.